Search research articles
Contact Us
Filters
Showing results (201-210 of 464) with videos related to
Page
of 47
Sort By:
Canadian Journal of Gastroenterology & Hepatology
|
February 17, 2025
Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data
David C Sealey, Kai Fai Ho, Z Christina Zhou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 1, 2024
Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod
Fernando Magro, Laurent Peyrin-Biroulet, Bruce E Sands, et al.
Annals of the Rheumatic Diseases
|
January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Gastroenterology
|
September 27, 2013
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis
Brian G Feagan, William J Sandborn, Andreas Lazar, et al.
Contemporary Clinical Trials
|
October 8, 2022
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
Brian G Feagan, Stefan Schreiber, Anita Afzali, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis
Jaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis
Jaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Journal of Crohn'S & Colitis
|
April 9, 2025
Association of bile acid diarrhea with symptoms and disease activity in Crohn's disease: post-hoc clinical trial analysis of serum 7a-hydroxy-4cholestern-3-one, C4, in patients with active Crohn's disease
Robert Battat, Soumya Kandi, Ana P Lacerda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2020
Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis
Christopher Ma, Jenny Jeyarajah, Leonardo Guizzetti, et al.
Gastroenterology
|
July 8, 2019
Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
Silvio Danese, William J Sandborn, Jean-Frédéric Colombel, et al.
Page
of 47
Search research articles
Search
Showing results (201-210 of 464) with videos related to
Sort By:
Page
of 47
Canadian Journal of Gastroenterology & Hepatology
|
February 17, 2025
Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data
David C Sealey, Kai Fai Ho, Z Christina Zhou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 1, 2024
Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod
Fernando Magro, Laurent Peyrin-Biroulet, Bruce E Sands, et al.
Annals of the Rheumatic Diseases
|
January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Gastroenterology
|
September 27, 2013
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis
Brian G Feagan, William J Sandborn, Andreas Lazar, et al.
Contemporary Clinical Trials
|
October 8, 2022
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
Brian G Feagan, Stefan Schreiber, Anita Afzali, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis
Jaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis
Jaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Journal of Crohn'S & Colitis
|
April 9, 2025
Association of bile acid diarrhea with symptoms and disease activity in Crohn's disease: post-hoc clinical trial analysis of serum 7a-hydroxy-4cholestern-3-one, C4, in patients with active Crohn's disease
Robert Battat, Soumya Kandi, Ana P Lacerda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2020
Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis
Christopher Ma, Jenny Jeyarajah, Leonardo Guizzetti, et al.
Gastroenterology
|
July 8, 2019
Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
Silvio Danese, William J Sandborn, Jean-Frédéric Colombel, et al.
Page
of 47